{
    "title": "AstraZeneca shares jump as pharma giant hails 'huge step forward' with successful trial of breast cancer drug",
    "url": "https://www.dailymail.co.uk/money/markets/article-10534963/AstraZeneca-shares-jump-step-forward-breast-cancer-treatment.html",
    "date": "2022-02-21",
    "keywords": [
        "cancer",
        "astrazeneca",
        "drug",
        "breast",
        "cent",
        "trial",
        "share",
        "monday",
        "enhertu",
        "profit",
        "fund",
        "group",
        "progression",
        "protein",
        "treatment",
        "dividend",
        "time",
        "decade",
        "money",
        "price",
        "disease",
        "revenue",
        "year",
        "susan",
        "vicepresident",
        "oncology",
        "vaccine",
        "investment",
        "account",
        "fee",
        "giant",
        "latestage",
        "week",
        "ftse",
        "her2",
        "survival",
        "conditionaround",
        "europe",
        "partnership",
        "firm",
        "success",
        "her2astrazeneca",
        "medication",
        "chemotherapyit",
        "world",
        "medicine",
        "announcement",
        "phase",
        "lynparza",
        "prostate",
        "line",
        "nhs",
        "covid",
        "multibillion",
        "pound",
        "deal",
        "article",
        "data",
        "experiment",
        "hormone",
        "therapy",
        "advance",
        "treatmentlynparza",
        "enhertubut",
        "research",
        "development",
        "business",
        "gamechanger",
        "galbraith",
        "executive",
        "rd",
        "treatedshe",
        "step",
        "ability",
        "spectrum",
        "expression",
        "need",
        "way",
        "cancerabout",
        "proportion",
        "lifetime",
        "age",
        "condition",
        "trading",
        "higher",
        "value",
        "loss",
        "covid19",
        "university",
        "oxforduntil",
        "coronavirus",
        "cost",
        "record",
        "lung",
        "bluechip",
        "operating",
        "half",
        "performance",
        "growth",
        "companion"
    ],
    "category": [
        "money",
        "markets"
    ]
}